![Emil Coccaro](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emil Coccaro
Corporate Officer/Principal chez Azevan Pharmaceuticals, Inc.
Postes actifs de Emil Coccaro
Sociétés | Poste | Début | Fin |
---|---|---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Corporate Officer/Principal | - | - |
Historique de carrière de Emil Coccaro
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
- Bourse
- Insiders
- Emil Coccaro
- Expérience